Cargando…

A systematic review of the effects of CYP2D6 phenotypes on risperidone treatment in children and adolescents

The second generation antipsychotic drug risperidone is widely used in the field of child and adolescent psychiatry to treat conditions associated with disruptive behavior, aggression and irritability, such as autism spectrum disorders. While risperidone can provide symptomatic relief for many patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dodsworth, Thomas, Kim, David D., Procyshyn, Ric M., Ross, Colin J., Honer, William G., Barr, Alasdair M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048722/ https://www.ncbi.nlm.nih.gov/pubmed/30026806 http://dx.doi.org/10.1186/s13034-018-0243-2

Ejemplares similares

A comparison of the metabolic side-effects of the second-generation antipsychotic drugs risperidone and paliperidone in animal models
por: Boyda, Heidi N., et al.
Publicado: (2021)

CYP2D6 genotype and adverse events to risperidone in children and adolescents
por: Oshikoya, Kazeem A., et al.
Publicado: (2019)

Long-acting injectable antipsychotics for early psychosis: A comprehensive systematic review
por: Lian, Lulu, et al.
Publicado: (2022)

Association between Serum Lipids and Antipsychotic Response in Schizophrenia
por: Kim, David D., et al.
Publicado: (2019)

M216. ASSOCIATIONS OF EXTRAPYRAMIDAL SYMPTOMS WITH PSYCHOTIC SYMPTOMS IN A COHORT OF HOMELESS OR PRECARIOUSLY HOUSED PERSONS WITH OR WITHOUT SCHIZOPHRENIA
por: Kim, David, et al.
Publicado: (2020)

Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review
por: Yuen, Jessica W. Y., et al.
Publicado: (2018)

Efficacy and tolerability of aripiprazole versus D(2) antagonists in the early course of schizophrenia: a systematic review and meta-analysis
por: Kim, David D., et al.
Publicado: (2021)

Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis
por: Lee, Lik Hang N., et al.
Publicado: (2018)

A Focused Review of the Metabolic Side-Effects of Clozapine
por: Yuen, Jessica W. Y., et al.
Publicado: (2021)

CYP2D6 polymorphisms and their influence on risperidone treatment
por: Puangpetch, Apichaya, et al.
Publicado: (2016)

Developing prediction models for symptom severity around the time of discharge from a tertiary-care program for treatment-resistant psychosis
por: Lee, Lik Hang N., et al.
Publicado: (2023)

Management of Medication-Related Cardiometabolic Risk in Patients with Severe Mental Illness
por: Lang, Donna J., et al.
Publicado: (2013)

Exercise and Worsening of Extrapyramidal Symptoms during Treatment with Long-Acting Injectable Antipsychotics
por: Kim, David D., et al.
Publicado: (2021)

Metabolic Side-Effects of the Novel Second-Generation Antipsychotic Drugs Asenapine and Iloperidone: A Comparison with Olanzapine
por: Boyda, Heidi N., et al.
Publicado: (2013)

Antipsychotic Drug-Induced Increases in Peripheral Catecholamines are Associated With Glucose Intolerance
por: Boyda, Heidi N., et al.
Publicado: (2022)

CYP2D6 Genotype-Based Dose Recommendations for Risperidone in Asian People
por: Cui, Yuanxia, et al.
Publicado: (2020)

Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone
por: Lu, Jinjun, et al.
Publicado: (2021)

Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review
por: Yin, John, et al.
Publicado: (2017)

Population pharmacokinetics and dosing of long-acting injectable antipsychotics
por: Kim, David D., et al.
Publicado: (2021)

Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines
por: Boyda, Heidi N., et al.
Publicado: (2020)

Relationship between CYP2D6 genotype, activity score and phenotype in a pediatric Thai population treated with risperidone
por: Hongkaew, Yaowaluck, et al.
Publicado: (2021)

Characterization of mental health in cannabis dispensary users, using structured clinical interviews and standardized assessment instruments
por: Yau, Jade C., et al.
Publicado: (2019)

An Evaluation of the Effects of the Novel Antipsychotic Drug Lurasidone on Glucose Tolerance and Insulin Resistance: A Comparison with Olanzapine
por: Wu, Claire, et al.
Publicado: (2014)

Risperidone-associated adverse drug reactions and CYP2D6 polymorphisms in a South African cohort
por: Dodgen, Tyren M., et al.
Publicado: (2015)

A retrospective study of antipsychotic drug switching in a pediatric population
por: Linton, David, et al.
Publicado: (2013)

Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents
por: Dos Santos-Júnior, Amilton, et al.
Publicado: (2016)

Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach
por: Kneller, Lisa Alina, et al.
Publicado: (2020)

Association of CYP2D6 polymorphisms and extrapyramidal symptoms in schizophrenia patients receiving risperidone: a retrospective study
por: Ito, Takahiro, et al.
Publicado: (2018)

The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients
por: Lenk, Hasan Çağın, et al.
Publicado: (2022)

Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with Tramadol
por: Rodieux, Frédérique, et al.
Publicado: (2023)

Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and Risperidone
por: Rüdesheim, Simeon, et al.
Publicado: (2022)

Risperidone treatment for ADHD in children and adolescents with bipolar disorder
por: Biederman, Joseph, et al.
Publicado: (2008)

Corrigendum to “Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents”
por: Dos Santos-Júnior, Amilton, et al.
Publicado: (2017)

Risperidone for children and adolescents with autism spectrum disorder: a systematic review
por: Maneeton, Narong, et al.
Publicado: (2018)

Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
por: Canitano, Roberto, et al.
Publicado: (2008)

White matter deficits assessed by diffusion tensor imaging and cognitive dysfunction in psychostimulant users with comorbid human immunodeficiency virus infection
por: Tang, Victor M., et al.
Publicado: (2015)

Cognitive decline and mortality in a community-based sample of homeless and precariously housed adults: 9-year prospective study
por: Gicas, Kristina M., et al.
Publicado: (2020)

A Prospective Study to Evaluate the Effect of CYP2D6 Polymorphism on Plasma level of Risperidone and its Metabolite in North Indian Patients with Schizophrenia
por: Chavan, Bir S., et al.
Publicado: (2018)

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
por: Hongkaew, Yaowaluck, et al.
Publicado: (2015)

META-ANALYSIS OF CYP2D6 METABOLIZER PHENOTYPE AND METOPROLOL PHARMACOKINETICS
por: Blake, CM, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3a6bc530h0d7hv021c9k1b9r8q